Stemline Therapeutics Inc (NASDAQ:STML)

13.25
Delayed Data
As of May 21
 -0.30 / -2.21%
Today’s Change
10.50
Today|||52-Week Range
18.94
-22.33%
Year-to-Date
No recent news for Stemline Therapeutics Inc.

Today’s Trading

Previous close13.55
Today’s open13.59
Day’s range-- - --
Volume140,617
Average volume (3 months)114,187
Market cap$237.3M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)+5.11%
Earnings growth (this year)+14.86%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.18

Competitors

 Today’s
change
Today’s
% change
ASMBAssembly Biosciences...+0.10+0.70%
INNLInnocoll AG-0.00-0.00%
MSLIMerus Labs Internati...+0.03+1.27%
AKBAAkebia Therapeutics ...-0.02-0.25%
Data as of 05/21/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$0.00
Annual profit (last year)-$28.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ivan Bergstein
Chief Operating Officer &
Secretary
Kenneth Hoberman
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers